Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues : Facts and controversiesROBAK, Tadeusz.Drugs & aging. 2005, Vol 22, Num 12, pp 983-1012, issn 1170-229X, 30 p.Article

Acute lymphoblastic leukaemia in elderly patients: Biological characteristics and therapeutic approachesROBAK, Tadeusz.Drugs & aging. 2004, Vol 21, Num 12, pp 779-791, issn 1170-229X, 13 p.Article

Older and new purine nucleoside analogs for patients with acute leukemiasROBAK, Pawel; ROBAK, Tadeusz.Cancer treatment reviews. 2013, Vol 39, Num 8, pp 851-861, issn 0305-7372, 11 p.Article

Purine Nucleoside Analogs in the Treatment of Rarer Chronic Lymphoid Leukemias : The Importance of Rational Chemotherapy of Chronic Lymphocytic LeukemiaROBAK, Tadeusz; ROBAK, Pawel.Current pharmaceutical design (Print). 2012, Vol 18, Num 23, pp 3373-3388, issn 1381-6128, 16 p.Article

Influence of gemcitabine (2', 2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitroLECH-MARANDA, Ewa; KORYCKA, Anna; ROBAK, Tadeusz et al.European journal of haematology. 2000, Vol 65, Num 5, pp 317-321, issn 0902-4441Article

Current and Emerging Treatments for Chronic Lymphocytic LeukaemiaROBAK, Tadeusz; JAMROZIAK, Krzysztof; ROBAK, Pawel et al.Drugs (Basel). 2009, Vol 69, Num 17, pp 2415-2449, issn 0012-6667, 35 p.Article

Inhibited apoptosis of synovial fluid lymphocytes in children with juvenile idiopathic arthritis is associated with increased expression of myeloid cell leukemia 1 and XIAP proteinsSMOLEWSKA, Elzbieta; STANCZYK, Jerzy; ROBAK, Tadeusz et al.Journal of rheumatology. 2006, Vol 33, Num 8, pp 1684-1690, issn 0315-162X, 7 p.Article

Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitroSZMIGIELSKA-KAPLON, Anna; CIESIELSKA, Ewa; SZMIGIERO, Leszek et al.European journal of haematology. 2002, Vol 68, Num 6, pp 370-375, issn 0902-4441Article

Current and Emerging Therapies for Acute Myeloid LeukemiaROBAK, Tadeusz; WIERZBOWSKA, Agnieszka.Clinical therapeutics. 2009, Vol 31, Num THEM, pp 2349-2370, issn 0149-2918, 22 p., 2Article

Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cellsKOBYLINSKA, Agnieszka; BLONSKI, Jerzy Z; HANAUSEK, Malgorzata et al.Oncology reports. 2004, Vol 11, Num 3, pp 699-705, issn 1021-335X, 7 p.Article

Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosusROBAK, Ewa; KULCZYCKA, Lilianna; SYSA-JEDRZEJOWSKA, Anna et al.European cytokine network (Montrouge). 2007, Vol 18, Num 4, pp 181-187, issn 1148-5493, 7 p.Article

Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosusROBAK, Ewa; WIERZBOWSKA, Agnieszka; CHMIELA, Magdalena et al.Mediators of inflammation. 2006, Vol 2006, Num 1, issn 0962-9351, C1-C7Article

No influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cellsJAMROZIAK, Krzysztof; BALCERCZAK, Ewa; CEBULA, Barbara et al.Therapeutic drug monitoring. 2006, Vol 28, Num 5, pp 707-711, issn 0163-4356, 5 p.Article

Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignanciesROBAK, Tadeusz; GORA-TYBOR, Joanna; LECH-MARANDA, Ewa et al.European journal of haematology. 2001, Vol 66, Num 3, pp 188-194, issn 0902-4441Article

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)KANTARJIAN, Hagop M; SHAH, Neil P; PAVLOVSKY, Carolina et al.Blood. 2012, Vol 119, Num 5, pp 1123-1129, issn 0006-4971, 7 p.Article

Effect of FCGR2A and FCGR3A variants on CLL outcomeDORNAN, David; SPLEISS, Olivia; WARZOCHA, Krzysztof et al.Blood. 2010, Vol 116, Num 20, pp 4212-4222, issn 0006-4971, 11 p.Article

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia : final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trialROBAK, Tadeusz; JAMROZIAK, Krzysztof; WOJTASZKO, Maria et al.Blood. 2007, Vol 109, Num 9, pp 3672-3675, issn 0006-4971, 4 p.Article

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib : a randomized phase 2 trial. CommentarySCHIFFER, Charles A; KANTARJIAN, Hagop; SKOTNICKI, Aleksander et al.Blood. 2007, Vol 109, Num 12, issn 0006-4971, 5068-5069, 5143-5150 [10 p.]Article

Lack of effect of repeated suberythemal ultraviolet-B exposures on human blood dendritic subtypesNARBUTT, Joanna; LESIAK, Aleksandra; SKIBINSKA, Malgorzta et al.Photodermatology photoimmunology & photomedicine. 2005, Vol 21, Num 5, pp 249-253, issn 0905-4383, 5 p.Article

Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignanciesSMOLEWSKI, Piotr; ROBAK, Pawel; CEBULA-OBRZUT, Barbara et al.European journal of cancer (1990). 2014, Vol 50, Num 15, pp 2677-2684, issn 0959-8049, 8 p.Article

Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III StudyHOLOWIECKI, Jerzy; GROSICKI, Sebastian; KLOCZKO, Janusz et al.Journal of clinical oncology. 2012, Vol 30, Num 20, pp 2441-2448, issn 0732-183X, 8 p.Article

The Effect of Repeated Exposures to Low-Dose UV Radiation on the Apoptosis of Peripheral Blood Mononuclear CellsNARBUTT, Joanna; CEBULA, Barbara; LESIAK, Aleksandra et al.Archives of dermatology (1960). 2009, Vol 145, Num 2, pp 133-138, issn 0003-987X, 6 p.Article

Randomized Comparison of Cladribine Alone or in Combination With Cyclophosphamide, and Cyclophosphamide, Vincristine and Prednisone in Previously Untreated Low-Grade B-Cell Non-Hodgkin Lymphoma Patients : Final Report of the Polish Lymphoma Research GroupKALINKA-WARZOCHA, Ewa; WAJS, Jaroslaw; LECH-MARANDA, Ewa et al.Cancer. 2008, Vol 113, Num 2, pp 367-375, issn 0008-543X, 9 p.Article

Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcomeJUSZCZYNSKI, Przemyslaw; KALINKA, Ewa; SALLES, Gilles et al.Blood. 2002, Vol 100, Num 8, pp 3037-3040, issn 0006-4971, 4 p.Article

A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemiaAWAN, Farrukh T; HILLMEN, Peter; HELLMANN, Andrzej et al.British journal of haematology. 2014, Vol 167, Num 4, pp 466-477, issn 0007-1048, 12 p.Article